Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 28;27(147):170125.
doi: 10.1183/16000617.0125-2017. Print 2018 Mar 31.

Personalised pulmonary rehabilitation in COPD

Affiliations
Review

Personalised pulmonary rehabilitation in COPD

Emiel F M Wouters et al. Eur Respir Rev. .

Abstract

This review summarises ongoing developments in personalised medicine and individualised medicine in chronic obstructive pulmonary disease (COPD). Currently applied classification systems largely ignore the complexity and heterogeneity of the COPD syndrome. Personalised medicine has to consider the influence of unique circumstances of the person, which contribute to this heterogeneity and complexity. Pulmonary rehabilitation is described as a comprehensive, individualised intervention based on thorough assessment of identifiable treatable traits. Partnership in care will become a crucial factor to improve and maintain health. Tolerating uncertainty and unpredictability will enrich future doctor-patient relationships.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: E.F.M. Wouters is a board member for Nycomed and Boehringer Ingelheim. He has received grants from AstraZeneca and GSK, and has received speakers’ fees from AstraZeneca, GlaxoSmithKline, Novartis and Chiesi.

Figures

FIGURE 1
FIGURE 1
Examples of personal barriers and enablers that both encourage and limit participation in physical activity for patients with chronic obstructive pulmonary disease (COPD). PA: physical activity. Reproduced from [37] with permission.
FIGURE 2
FIGURE 2
The process of a tailored programme including the three core processes (baseline assessment, tailored treatment and outcome assessment). Reproduced from [41] with permission.

References

    1. Speizer FE, Ware JH. Exploring different phenotypes of COPD. N Engl J Med 2015; 373: 185–186. - PubMed
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management and Prevention of COPD – 2016. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd...
    1. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693–718. - PubMed
    1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645–1648. - PMC - PubMed
    1. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728–735. - PubMed

MeSH terms

LinkOut - more resources